The SARS-CoV-2 pandemic poses an unprecedented challenge to the medical community. COVID-19 is potentially devastating for elderly patients, those who have comorbidities, as well as those with chronic hematological conditions.
Exceptional measures have been implemented by hospitals to prevent the spread of the virus and ensure optimal access to care for everyone, without jeopardizing the chances of recovery for patients with curable diseases. The hematological societies have issued guidelines that we summarize in this article for the diseases most commonly treated in our center, in the light of our experience.
Key Words
Myeloma, lymphoma, leukemia, transplantation, hemoglobinopathies, febrile neutropenia, idiopathic thrombopenic purpura, COVID-19